MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
This Quarter Return
-12.3%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$282M
AUM Growth
+$282M
(-15%)
Cap. Flow
+$358K
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
39.53%
Holding
78
New
–
Increased
17
Reduced
43
Closed
5
Top Buys
| 1 |
Amazon
AMZN
|
$4.04M |
| 2 |
Medtronic
MDT
|
$1.2M |
| 3 |
NVIDIA
NVDA
|
$1.09M |
| 4 |
Aptiv
APTV
|
$442K |
| 5 |
Edwards Lifesciences
EW
|
$365K |
Top Sells
| 1 |
Unilever
UL
|
$1.95M |
| 2 |
Becton Dickinson
BDX
|
$795K |
| 3 |
Apple
AAPL
|
$537K |
| 4 |
Automatic Data Processing
ADP
|
$364K |
| 5 |
Intel
INTC
|
$292K |
Sector Composition
| 1 | Healthcare | 26.92% |
| 2 | Technology | 22.59% |
| 3 | Industrials | 12.48% |
| 4 | Financials | 7.78% |
| 5 | Consumer Staples | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TJX Companies
TJX
$152B
| $4.17M | 1.48% |
74,647
+209
| +0.3% | +$11.7K |
|
27
Xylem
XYL
$34.5B
| $3.9M | 1.38% |
49,835
+1,866
| +4% | +$146K |
|
28
Exxon Mobil
XOM
$487B
| $3.49M | 1.24% |
40,735
-975
| -2% | -$83.5K |
|
29
Nike
NKE
$114B
| $3.46M | 1.23% |
33,820
+1,627
| +5% | +$166K |
|
30
PepsiCo
PEP
$204B
| $3.18M | 1.13% |
19,064
-150
| -0.8% | -$25K |
|
31
Honeywell
HON
$139B
| $2.98M | 1.06% |
17,148
+290
| +2% | +$50.4K |
|
|
32
Intel
INTC
$107B
| $2.97M | 1.05% |
79,355
-7,815
| -9% | -$292K |
|
|
33
Medtronic
MDT
$119B
| $2.49M | 0.88% |
27,740
+13,412
| +94% | +$1.2M |
|
34
Illumina
ILMN
$15.8B
| $2.13M | 0.76% |
11,558
+917
| +9% | +$169K |
|
35
Merck
MRK
$210B
| $2.13M | 0.76% |
23,350
-350
| -1% | -$31.9K |
|
|
36
NVIDIA
NVDA
$4.24T
| $2.01M | 0.72% |
13,285
+7,181
| +118% | +$1.09M |
|
37
PayPal
PYPL
$67.1B
| $1.99M | 0.71% |
28,481
+2,475
| +10% | +$173K |
|
38
AbbVie
ABBV
$372B
| $1.95M | 0.69% |
12,708
-460
| -3% | -$70.4K |
|
|
39
Unilever
UL
$155B
| $1.94M | 0.69% |
42,304
-42,500
| -50% | -$1.95M |
|
40
McCormick & Company Non-Voting
MKC
$18.9B
| $1.61M | 0.57% |
19,350
-200
| -1% | -$16.6K |
|
|
41
Edwards Lifesciences
EW
$47.8B
| $1.37M | 0.49% |
14,415
+3,838
| +36% | +$365K |
|
42
Emerson Electric
EMR
$74.3B
| $1.16M | 0.41% |
14,642
-300
| -2% | -$23.8K |
|
|
43
Aptiv
APTV
$17.3B
| $1.12M | 0.4% |
12,610
+4,965
| +65% | +$442K |
|
44
Bank OZK
OZK
$5.91B
| $834K | 0.3% |
22,225
-3,000
| -12% | -$113K |
|
45
Eli Lilly
LLY
$657B
| $827K | 0.29% |
2,550
-200
| -7% | -$64.9K |
|
46
Berkshire Hathaway Class B
BRK.B
$1.09T
| $816K | 0.29% |
2,990
-10
| -0.3% | -$2.73K |
|
47
Bristol-Myers Squibb
BMY
$96B
| $784K | 0.28% |
10,184
| – | – |
|
48
Union Pacific
UNP
$133B
| $768K | 0.27% |
3,600
-50
| -1% | -$10.7K |
|
49
Shell
SHEL
$215B
| $755K | 0.27% |
14,450
-1,150
| -7% | -$60.1K |
|
50
Visa
V
$683B
| $729K | 0.26% |
3,700
-40
| -1% | -$7.88K |
|